Sign Up to like & get
recommendations!
2
Published in 2023 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13409
Abstract: Immune checkpoint inhibitors (ICIs) targeting the PD‐1/PD‐L1 axis are the main therapeutic option for patients with advanced non‐small cell lung cancer (NSCLC) without a druggable oncogenic alteration. Nevertheless, only a portion of patients benefit from…
read more here.
Keywords:
whole genome;
checkpoint inhibitors;
genome sequencing;
benefit ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Clinical chemistry"
DOI: 10.1093/clinchem/hvac220
Abstract: BACKGROUND Somatic copy number alterations (sCNAs) acquired during the evolution of breast cancer provide valuable prognostic and therapeutic information. Here we present a workflow for screening sCNAs using picogram amounts of cell-free DNA (cfDNA) and…
read more here.
Keywords:
dna;
whole genome;
cell free;
amounts cell ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-223
Abstract: Endometrial carcinoma (EC) is the most common gynecologic cancer in North America. A clinically molecular classifier called ProMisE (Proactive Molecular Risk Classifier for Endometrial Cancer) was developed based on the TCGA classification. p53abn EC is…
read more here.
Keywords:
amplification;
shallow whole;
whole genome;
gene ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15020530
Abstract: Simple Summary Despite the progress in diagnostics and therapeutics, epithelial ovarian cancer (EOC) remains a fatal disease. Using shallow whole-genome sequencing (WGS), we identified copy number variations (CNVs). In addition, we quantified chromosomal instability using…
read more here.
Keywords:
whole genome;
genome sequencing;
survival;
cfdna ... See more keywords